Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
HIV Clinical Trials|April 25, 2013
High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccineTimothy Wilkin, Jeannette Y Lee, Shelly Y Lensing, et al.Current HIV Research|October 20, 2018
Prevalence of HIV in Patients with Malignancy and of Malignancy in HIV Patients in a Tertiary Care Center from North IndiaSanjeev Sinha, Ashish Agarwal, Kartik Gupta, et al.Plos One|May 26, 2010
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaJing Jie Yu, Pingfu Fu, John J Pink, et al.The Journal of Infectious Diseases|September 4, 2010
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected menTimothy Wilkin, Jeannette Y Lee, Shelly Y Lensing, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapySteven G Deeks, Bridget Wagner, Peter A Anton, et al.The Journal of Infectious Diseases|August 16, 2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral TherapyDeborah K McMahon, Lu Zheng, Joshua C Cyktor, et al.Cancer|January 30, 2014
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061Michelle A Rudek, Page C Moore, Ronald T Mitsuyasu, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 19, 2008
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapyRichard T Davey, Peter E Pertel, Alice Benson, et al.Science Translational Medicine|May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cellsJohn Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.Human Gene Therapy|March 17, 2004
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patientsRafael G Amado, Ronald T Mitsuyasu, Joseph D Rosenblatt, et al.Pageof 4